Liu Z#, Liu M#, Liu Y#, Zhou R#, Abliz A#, Yuan W, Guo C, Zhang L, He W, Zheng H, Huang Y, Pan Y, Liu F, Hu Z, Chen H, Cai H, He Z*, Ke Y*. Absence of Lugol staining indicates initiation of esophageal squamous cell carcinoma: A combined genomic and epidemiologic study,Cell Rep Med,

Qi Z#, Liu M#, Zhou R, Guo C, Liu A, Yang H, Li F, Duan L, Shen L, Wu Q, Wu N, Liu Z, Pan Y, Liu F, Liu Y, Cai H, He Z*, Ke Y*.,J Gastroenterol Hepatol,2023.38(3):416-423.

Liu M#, Liu Y#, Zhou R#, Liu Z, Guo C, Xu R, Li F, Liu A, Yang H, Zhang S, Shen L, Duan L, Wu Q, Zhao M, Su H, Liu F, Pan Y, Cai H, He Z*, Ke Y*.Absence of NOTCH1 mutation and presence of CDKN2A deletion predict progression of esophageal lesions.,J Pathol.,2022.258(1):38-48.

Liu M#, Zhou R#, Liu Z#, Guo C, Xu R, Zhou F, Liu A, Yang H, Li F, Duan L, Shen L, Wu Q, Zheng H, Tian H, Liu F, Liu Y, Pan Y, Chen H, Hu Z, Cai H, He Z*, and Ke Y*. Update and validation of a diagnostic model to identify prevalent malignant lesions in esophagus in general population.,EClinicalMedicine,47:101394.

Liu M#, Zhou R#, Guo C, Xu R, Liu A, Yang H, Li F, Duan L, Shen L, Wu Q, Liu Z, Liu F, Liu Y, Pan Y, Cai H, Weiss NS*, He Z*, Ke Y*. Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus.,Gastrointest Endosc.,2021.S0016-5107(20)34785-4

Zhou R#, Zheng H#, Liu M#, Liu Z#, Guo C, Tian H, Liu F, Liu Y, Pan Y, Chen H, Hu Z, Cai H, He Z*, Ke Y*.Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populations.,Chin J Cancer Res,2021.33(6):649-658.

Wang M#, Liu M#, Guo C, Li F, Liu Z, Pan Y, Liu F, Liu Y, Bao H, Hu Z, Cai H, He Z*, Ke Y*.Association of early-life undernutrition and risk of dyslipidemia in adulthood: a population-based cohort study.,BMC Public Health,2021.21(1):2129.

Wang MM, Guo CH, Li FL, Xu RP, Liu Z, Pan YQ, Liu FF, Liu Y, Cai H, Liu MF*, He ZH, Ke Y*.Family history of esophageal cancer modifies the association of serum lipids and malignant esophageal lesions: a nested case-control study from the "Endoscopic Screening for Esophageal Cancer in China" trial.,Chin Med J (Engl),2021.134(9):1079-1086.

Liu F#, Liu M#, Liu Y#, Guo C, Zhou Y, Li F, Xu R, Liu Z, Deng Q, Li X, Zhang C, Pan Y, Ning T, Dong X, Hu Z, Bao H, Cai H, Silva IDS, He Z*, Ke Y*.Oral microbiome and risk of malignant esophageal lesions in a high-risk area of China: A nested case-control study.,Chin J Cancer Res,2020.32(6):742-754.

Wang M#, Liu M#, Li F, Guo C, Liu Z, Pan Y, Liu Y, Liu F, Cai H, Wu Y, He Z*, Ke Y*.Gender heterogeneity in dyslipidemia prevalence, trends with age and associated factors in middle age rural Chinese.,Lipids Health Dis,2020.19(1):135.

Liu M#, Liu Z#, Liu F#, Guo C, Xu R, Li F, Liu A, Yang H, Zhang S, Shen L, Duan L, Wu Q, Cao C, Pan Y, Liu Y, Li J, Cai H, He Z*, Ke Y*.Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China.,Clin Gastroenterol Hepatol,2020.18(7):1626-1635.

Shi C#, Liu M#, Liu Z, Guo C, Li F, Xu R, Liu F, Liu Y, Li J, Cai H, He Z*, Ke Y*.Using health insurance reimbursement data to identify incident cancer cases.,J Clin Epidemiol,2019.114:141-149.

Liu M#, He Z#, Guo C, Xu R, Li F, Ning T, Pan Y, Li Y, Ding H, Zheng L, Zhou Y, Tian X, Yang W, Wang X, Lu F, Zhang Y, Zhao Y, Guo F, Chen K, Gao L, Sun M, Liu Y, Liu F, Hang D, Shen N, Li J, Xu Z, Wang Q, Zhang C, Abliz A, Deng Q, Li X, Liu Z, Zhang C, Yuan W, Wang H, Weiss NS*, Cai H*, Ke Y*.Effectiveness of Intensive Endoscopic Screening for Esophageal Cancer in China: A Community-Based Study.,Am J Epidemiol,2019.188(4):776-784.

He Z#, Liu Z#, Liu M#, Guo C, Xu R, Li F, Liu A, Yang H, Shen L, Wu Q, Duan L, Li X, Zhang C, Pan Y, Cai H*, Ke Y*.Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial.,Gut,2019.68(2):198-206.

2020年北京市科技新星计划, 北京市科技新星计划, 第1完成人, 北京大学医学部, 2021.9

食管癌前病变进展多组学预警标志物评估与预测模型构建, 课题负责人, 2022.1.1～2024.12.31, 北自然面上项目

基于人工智能技术建立食管癌碘染内镜筛查辅助诊断系统, 课题负责人, 2020.9.1～2023.8.31, 北京市科技新星

高发人群食管鳞癌癌前病变进展的风险预测与分级研究, 课题负责人, 2018.1.1～2021.12.31, 国自然面上项目

研究生招生计划

招生年度	招生专业	学位级别	学位类型	研究方向	选拔方式	操作
2024	流行病与卫生统计学	硕士	科学学位	肿瘤流行病学	推荐免试